logo

For the Inventor, By the Inventor

East Lyme, CT, United States of America

John Charles Murray

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Pfizer Corporation. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Charles Murray. Retrieved from https://idiyas.com/inventor/john-charles-murray

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal3 out of 4,486 
 
Pfizer Corporation
 patents

Years Active: 2017-2026

Loading Chart...
3 patents (USPTO):Explore Patents
1. 12637461 - Compounds for the activation of AMPK (2026-05-26),
2. 10112958 - N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-YL)-1,3-thiazol-4-YL] amides (2018-10-30),
3. 9751895 - N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides (2017-09-05),

Title: Innovations of John Charles Murray

Introduction

John Charles Murray is a notable inventor based in East Lyme, Connecticut. He has made significant contributions to the field of pharmaceuticals, holding two patents that reflect his innovative spirit and dedication to advancing medical science.

Latest Patents

Murray's latest patents include N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-YL)-1,3-thiazol-4-YL] amides. These inventions are directed towards compounds, tautomers, and pharmaceutically acceptable salts, which are disclosed in detail. The compounds have a specific structure defined in the patent, with variables R, R, and R as specified. Additionally, the patents cover corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates.

Career Highlights

Murray is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative treatments that can improve patient outcomes.

Collaborations

Murray has collaborated with notable colleagues, including Michael Aaron Brodney and Christopher Ryan Butler. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

John Charles Murray's contributions to the field of pharmaceuticals through his patents and work at Pfizer Corporation highlight his role as an influential inventor. His innovative approaches continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…